|
Index of reports
> Cases resulting in death (20)
Below is the selection of adverse event reports related to Epivir (Lamivudine) that includes cases resulting in death.
Adverse event in male receiving Epivir (Lamivudine)
Reported by a individual with unspecified qualification from Australia on 2007-10-22
Patient: male
Adverse reactions / side effects: Hepatitis
Adverse event resulted in: death
Suspect drug(s):
Hepsera
Administration route: Oral
Indication: Hepatitis B
Epivir
Administration route: Oral
Indication: Hepatitis B
Adverse event in receiving Epivir (Lamivudine)
Reported by a individual with unspecified qualification from Australia on 2007-10-15
Patient:
Adverse reactions / side effects: Hepatitis
Adverse event resulted in: death
Suspect drug(s):
Hepsera
Administration route: Oral
Indication: Hepatitis B
Epivir
Administration route: Oral
Indication: Hepatitis B
Adverse event in 36 year old male receiving Epivir (Lamivudine)
Reported by a individual with unspecified qualification from United States on 2007-07-23
Patient: 36 year old male
Adverse reactions / side effects: Immune Reconstitution Syndrome, Body Temperature Increased, Pleuritic Pain, Wheezing, Kaposi's Sarcoma, Pyrexia, Chest X-RAY Abnormal, Mycobacterium Avium Complex Infection, Acid Fast Bacilli Infection, Acute Respiratory Distress Syndrome, Crepitations, Sputum Culture Positive, Cough, Respiratory Rate Increased, Dyspnoea, Necrotising Granulomatous Lymphadenitis, Granuloma, Computerised Tomogram Abnormal, Human Herpesvirus 8 Infection, Bronchoalveolar Lavage Abnormal, Respiratory Failure, Inflammation
Adverse event resulted in: death
Suspect drug(s):
Epivir
Indication: Kaposi's Sarcoma
Tenofovir Disoproxil Fumarate
Indication: Kaposi's Sarcoma
Ritonavir (Formulation Unknown) (Ritonavir)
Indication: Kaposi's Sarcoma
Atazanavir (Formulation Unknown) (Atazanavir)
Indication: Kaposi's Sarcoma
Stealth Lip.doxorubicin (Formulation Unknown) (Stealth Lip.doxorubicin
Indication: Kaposi's Sarcoma
Adverse event in 32 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-07-13
Patient: 32 year old male
Adverse reactions / side effects: Multi-Organ Failure, Bone Marrow Failure
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Efavirenz
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Endoxan
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Retrovir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Epivir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Adriamycin PFS
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Oncovin
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Predonine
Administration route: Oral
Indication: Plasmablastic Lymphoma
Start date: 2006-02-23
End date: 2006-03-21
Ganciclovir Sodium
Indication: Cytomegalovirus Enterocolitis
Start date: 2006-06-30
End date: 2006-07-19
Other drugs received by patient: Pentamidine Isethionate
Adverse event in 32 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-05-11
Patient: 32 year old male
Adverse reactions / side effects: Multi-Organ Failure, Diarrhoea, Dehydration, Bone Marrow Failure
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Efavirenz
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Endoxan
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Retrovir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Epivir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Adriamycin PFS
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Oncovin
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Predonine
Administration route: Oral
Indication: Plasmablastic Lymphoma
Start date: 2006-02-23
End date: 2006-03-21
Ganciclovir Sodium
Indication: Cytomegalovirus Enterocolitis
Start date: 2006-06-30
End date: 2006-07-19
Other drugs received by patient: Pentamidine Isethionate
Adverse event in 45 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-05-11
Patient: 45 year old male, weighing 56.0 kg (123.2 pounds)
Adverse reactions / side effects: Pneumonia, Acute Respiratory Distress Syndrome, Pancytopenia, Histoplasmosis Disseminated, Pyrexia, Renal Failure Acute
Adverse event resulted in: death
Suspect drug(s):
Crixivan
Administration route: Oral
Indication: HIV Infection
Start date: 2001-08-27
End date: 2001-09-01
Retrovir
Indication: HIV Infection
Start date: 2001-08-27
End date: 2001-09-01
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2001-08-27
End date: 2001-09-01
[therapy Unspecified]
Administration route: Oral
Indication: Cerebral Toxoplasmosis
Start date: 2001-08-25
Clindamycin Hydrochloride
Administration route: Oral
Indication: Cerebral Toxoplasmosis
Start date: 2001-08-25
Adverse event in 32 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-05-08
Patient: 32 year old male
Adverse reactions / side effects: Multi-Organ Failure, Diarrhoea, Dehydration, Bone Marrow Failure
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Efavirenz
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Endoxan
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Retrovir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Epivir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Adriamycin PFS
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Oncovin
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Predonine
Administration route: Oral
Indication: Plasmablastic Lymphoma
Start date: 2006-02-23
End date: 2006-03-21
Ganciclovir Sodium
Indication: Cytomegalovirus Enterocolitis
Start date: 2006-06-30
End date: 2006-07-19
Other drugs received by patient: Pentamidine Isethionate
Adverse event in 32 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-04-23
Patient: 32 year old male
Adverse reactions / side effects: Renal Disorder, Diarrhoea, Dehydration, Bone Marrow Failure
Adverse event resulted in: death
Suspect drug(s):
Efavirenz
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Endoxan
Indication: Plasmablastic Lymphoma
Doxorubicin HCL
Indication: Plasmablastic Lymphoma
Oncovin
Indication: Plasmablastic Lymphoma
Epivir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Retrovir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Predonine
Indication: Plasmablastic Lymphoma
Adverse event in 52 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-04-03
Patient: 52 year old male
Adverse reactions / side effects: Oral Intake Reduced, Malnutrition, Pancytopenia, Lymphoma
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-14
End date: 2005-12-15
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-14
End date: 2005-12-15
Retrovir
Indication: HIV Infection
Start date: 2005-03-14
End date: 2005-05-08
Other drugs received by patient: Contomin; Silece; Lormetazepam; Tetramide; Paxil; Tenofovir Disoproxil Fumarate
Adverse event in 52 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-03-30
Patient: 52 year old male
Adverse reactions / side effects: White Blood Cell Count Decreased, Haemoglobin Decreased, Malnutrition, Pancytopenia, Lymphoma, Lymphocyte Count Decreased, Eating Disorder
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Epivir
Dosage: 300mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-14
End date: 2005-12-15
Retrovir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-14
End date: 2005-05-08
Stocrin
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-14
End date: 2005-12-15
Other drugs received by patient: Viread; Paxil; Lexotan; Tetramide; Evamyl; Contomin; Silece
Adverse event in 52 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-02-21
Patient: 52 year old male
Adverse reactions / side effects: Oral Intake Reduced, Malnutrition, Pancytopenia, Lymphoma
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-14
End date: 2005-12-15
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-14
End date: 2005-12-15
Retrovir
Indication: HIV Infection
Start date: 2005-03-14
End date: 2005-05-08
Other drugs received by patient: Contomin; Silece; Lormetazepam; Tetramide; Paxil; Tenofovir
Adverse event in male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-02-15
Patient: male
Adverse reactions / side effects: Epstein-Barr Virus Infection, Oliguria, Renal Failure Acute
Adverse event resulted in: death
Suspect drug(s):
Epivir (Lamivudine)
Other drugs received by patient: Zerit; Norvir; Stocrin; Reyataz; Zithromac; Isoniazid; Ethambutol HCL; Levofloxacin
Adverse event in 52 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-02-12
Patient: 52 year old male
Adverse reactions / side effects: White Blood Cell Count Decreased, Haemoglobin Decreased, Malnutrition, Pancytopenia, Lymphoma, Lymphocyte Count Decreased, Eating Disorder
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Epivir
Dosage: 300mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-14
End date: 2005-12-15
Retrovir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-14
End date: 2005-05-08
Stocrin
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-14
End date: 2005-12-15
Other drugs received by patient: Viread; Paxil; Lexotan; Tetramide; Evamyl; Contomin; Silece
Adverse event in 58 year old male receiving Epivir (Lamivudine)
Reported by a individual with unspecified qualification from Brazil on 2007-01-26
Patient: 58 year old male
Adverse reactions / side effects: Drug Resistance, Condition Aggravated, Hepatic Failure, Hepatitis B
Adverse event resulted in: death
Suspect drug(s):
Epivir (Lamivudine)
Adverse event in 55 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-01-24
Patient: 55 year old male
Adverse reactions / side effects: Jaundice, Hepatic Neoplasm Malignant, Hepatic Cirrhosis
Adverse event resulted in: death
Suspect drug(s):
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 1997-06-24
End date: 2005-07-19
Retrovir
Administration route: Oral
Indication: HIV Infection
Start date: 1996-07-29
End date: 2005-07-03
Viread
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2005-07-04
End date: 2005-07-19
Other drugs received by patient: Tenormin; Amlodipine Besylate; Recombinate; Novoseven; Rebetol; Pegasys
Adverse event in male receiving Epivir (Lamivudine)
Reported by a physician from Luxembourg on 2007-01-24
Patient: male, weighing 75.0 kg (165.0 pounds)
Adverse reactions / side effects: Blood Triglycerides Increased
Adverse event resulted in: death
Suspect drug(s):
Epivir
Dosage: 300mg per day
Actos
Dosage: 30mg per day
Start date: 2006-03-01
Other drugs received by patient: Diamicron; Glucophage; Atacand; Lipitor; Stocrin; Viread; Unknown Drug
Adverse event in male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-01-23
Patient: male, weighing 56.0 kg (123.2 pounds)
Adverse reactions / side effects: Dysarthria, Soliloquy, Leukoencephalomyelitis, Encephalopathy, Depressed Level of Consciousness, Disorientation, Cerebral Haemorrhage
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Ziagen
Dosage: 300mg twice per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Zerit
Dosage: 30mg twice per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Other drugs received by patient: Selbex; Landsen; Unknown Drug; Adona (AC-17); Carnaculin; Juvela Nicotinate; Novoseven; Tienam; Meropen; SOL-Melcort; Predonine; Diflucan
Adverse event in 49 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from France on 2007-01-19
Patient: 49 year old male
Adverse reactions / side effects: White Blood Cell Count Decreased, Weight Decreased, Haemoglobin Decreased, Agranulocytosis, General Physical Health Deterioration, Pancytopenia, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
Ziagen
Dosage: 600mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
Triflucan
Dosage: 50mg per day
Administration route: Oral
Start date: 2006-12-01
End date: 2006-12-14
Moxifloxacin Hydrochloride
Dosage: 400mg per day
Administration route: Oral
Indication: Mycobacterial Infection
Start date: 2006-11-28
End date: 2006-12-11
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
Bactrim
Start date: 2006-01-01
End date: 2006-12-04
Other drugs received by patient: Clarithromycin; Ethambutol HCL; Valganciclovir HCL; Prazepam; Effexor
Adverse event in 50 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-01-18
Patient: 50 year old male
Adverse reactions / side effects: Agranulocytosis, Pancytopenia
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Moxifloxacin Hydrochloride
Dosage: total daily dose: 400 mg unit dose: 400 mg
Administration route: Oral
Indication: Mycobacterial Infection
Start date: 2006-11-29
End date: 2006-12-11
Triflucan
Dosage: unit dose: 50 mg
Administration route: Oral
Indication: Unevaluable Event
Start date: 2006-12-01
End date: 2006-12-11
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
End date: 2006-11-28
Norvir
Start date: 2006-12-02
End date: 2006-12-11
Epivir
Dosage: unit dose: 300 mg
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
End date: 2006-11-28
Epivir
Start date: 2006-12-02
End date: 2006-12-15
Ziagen
Dosage: unit dose: 600 mg
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
End date: 2006-11-28
Ziagen
Start date: 2006-12-02
End date: 2006-12-11
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
End date: 2006-11-28
Reyataz
Start date: 2006-12-02
End date: 2006-12-11
Other drugs received by patient: Bactrim; Bactrim; Clarithromycin; Ethambutol Hydrochloride; Cymevan; Rovalcyte; Prazepam; Effexor
Adverse event in 49 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-01-18
Patient: 49 year old male
Adverse reactions / side effects: Weight Decreased, Agranulocytosis, General Physical Health Deterioration, Pancytopenia, Urethritis, Infection
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
End date: 2006-11-28
Reyataz
Dosage: gastric catheter
Indication: HIV Infection
Start date: 2006-12-02
Ziagen
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
End date: 2006-11-28
Ziagen
Dosage: via gastric catheter
Start date: 2006-12-02
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
End date: 2006-11-28
Epivir
Dosage: via gastric catheter
Start date: 2006-12-02
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
End date: 2006-11-28
Norvir
Dosage: gastric catheter
Start date: 2006-12-02
Moxifloxacin Hydrochloride
Administration route: Oral
Start date: 2006-11-28
Triflucan
Administration route: Oral
Other drugs received by patient: Clarithromycin; Ethambutol Hydrochloride; Cymevan; Rovalcyte; Bactrim; Triflucan; Prazepam; Effexor
|
